A vitally important part of early detections is submitting to a prostate cancer screening. This includes a PSA (prostate specific antigen) blood test and a digital rectal exam by a physician.
PSA is an enzyme that is produced by the prostate. When a patient comes into the Chicago Prostate Center for a screening, he is submitted to a PSA blood test that determines the amount of antigen in the bloodstream, as well as an examination to assess the prostate for any abnormalities. Normally men will have a low level of PSA in the blood, but a high level can be an indicator of prostate cancer. Results vary from person to person, but usually a PSA level of 4.0 ng/ml or higher or a rise in the PSA from the previous year is cause for further evaluation. An elevated PSA level does not necessarily mean a positive diagnosis, as elevated PSA levels can be caused be various other factors including infection, swelling, or benign prostate hyperplasia (BPH). However, anyone with an elevated PSA level should consult their physician to see if a biopsy is necessary.
Chicago Prostate Center has developed an advanced biopsy technique called Stereotactic Transperineal Prostate Biopsy (STPB) that diagnoses over 40% more cancer than a standard biopsy. For more information or to schedule a consultation with CPC, please call 630-654-2515 or visit prostateimplant.com/contact